FOXO Technologies
Transforming health and longevity insights through epigenetic biomarker technology for insurance underwriting and healthcare services.
Overview
FOXO Technologies, Inc. is a healthcare services and technology company that originated as an insurtech focused on transforming the global longevity insurance industry through epigenetic biomarker technology. The company applies automated machine learning and AI technologies to discover epigenetic biomarkers of human health, wellness, and aging, offering a saliva-based alternative to traditional blood and urine testing used in life insurance underwriting.
Founded by Jon R. Sabes, the company went public in September 2022 through a SPAC merger with Delwinds Insurance Acquisition Corp., listing on the NYSE American under the ticker FOXO. Since then, the company has expanded into a diversified healthcare platform operating through four wholly owned subsidiaries: an epigenetics diagnostics division, rural hospital operations (Rennova Community Health / Big South Fork Medical Center), behavioral health facilities (Myrtle Recovery Centers), and biospecimen research services (Vector BioSource).
As of late 2025, the company reported approximately $15 million in annual net revenues. FOXO lost its NYSE American listing in Q3 2025 due to minimum share price requirements and now trades on the OTC market, with a market capitalization of approximately $193K as of January 2026.
Products & Services
FOXO Labs - Epigenetic Biomarker Technology
Proprietary epigenetic biomarker platform that enables saliva-based health and wellness assessments for life insurance underwriting, replacing traditional invasive blood and urine specimen requirements.
Key Features
- Saliva-based sample collection for non-invasive testing
- Analysis of DNA methylation at over 860,000 CpG sites along the epigenome
- AI and machine learning models to identify health, wellness, and aging biomarkers
- Integration with Illumina microarray technology for biomarker detection
Target Users: Life insurance carriers, reinsurers, underwriters
FOXO Life - Consumer Engagement Platform
Consumer-facing platform that translates epigenetic science into practical insurance products and wellness insights, including the FOXO Longevity Report.
Key Features
- FOXO Longevity Report providing biological age insights based on the epigenetic clock
- Proprietary wellness measures derived from epigenetic biomarkers
- Digital experience for insurance product delivery
- Integration with SCOR Velogica automated underwriting engine
Target Users: Life insurance consumers, policyholders
Bioinformatics Services
Data solutions using AI and machine learning for academia, healthcare, government, and pharmaceutical research customers.
Key Features
- AI-driven bioinformatics and data analysis
- Custom biomarker research and development
- Epigenetic research collaboration services
Target Users: Research institutions, pharmaceutical companies, healthcare organizations
Vector BioSource - Biospecimen Services
AI-powered platform for biospecimen sourcing, providing researchers access to preserved biological samples including whole blood, bulk serum, and toxicology urine specimens.
Key Features
- AI-powered biospecimen sourcing platform
- Access to preserved biological samples
- Serving biotechnology and pharmaceutical research sectors
Target Users: Biotech and pharma researchers
Healthcare Facilities
FOXO operates healthcare facilities through subsidiaries, though these are not directly insurance-related. Rennova Community Health / Big South Fork Medical Center:
Key Features
- 25-bed Critical Access Hospital in Oneida, Tennessee
- Emergency, inpatient, outpatient, and ancillary services
- Over 7,000 ER visits and 3,500 outpatient visits annually (2025)
- 30-bed behavioral health facility in Oneida, Tennessee
- Medication-assisted treatment, detox, and residential treatment
- 93% average occupancy in 2025
At a Glance
- Founded
- 2016
- Headquarters
- West Palm Beach, FL
- Employees
- 51-200
- Funding
- Public
Category & Focus
- Category
- Underwriting & Risk
- Subcategories
- Epigenetic biomarkers AI-driven bioinformatics risk assessment technology
- Insurance Verticals
- Life & Annuity
- Target Customers
- Carriers, Reinsurers
Customers
- [Unknown]
Similar Companies
-
Relativity6 🤖AI-powered risk data platform for business classification, KYB verification, and commercial underwriting automation. -
RedZoneIntelligent wildfire and natural disaster intelligence for insurance, utilities, and emergency response. -
RRGAXTransforming the future of life insurance through innovation, technology, and strategic partnerships.
-
QuantumergeThe first AI-powered platform for M&A transactional risk insurance -- streamlining R&W underwriting from submission to binding. -
QQuanteeAI-driven insurance pricing software for carriers and MGAs -- acquired by Guidewire in 2025
-
PPrevisicoReal-time, property-level flood forecasting and intelligence for insurers and risk managers
Last updated: 2026-03-25